Pfizer's Conor Riordan explains how the pharmaceutical giant uses Celonis across 200+ markets to drive toward 95% order ...

The debut of IVP is more than an addition to a Hype Cycle – it’s a wake-up call. Enterprises can no longer afford to operate ...